Loading...
Trading.HK
Global Markets
T.HK
News Markets

Menu

Home
Asia
Hong Kong China Japan India Singapore Taiwan
Americas
US Canada Brazil Mexico
Europe & Others
UK Germany France Australia
View All Markets →
Traditional Assets
Equities Options ETFs Bonds
Alternative Assets
Cryptocurrency Forex Commodities app.nav.macro
News
Market Analysis
Correlation Matrix Risk-Return Profile Market Sentiment Momentum Signals
View All Analytics →
Screener Compare Search Market Status
/ News / app.categories.earnings

News

All News
By Category
Central Banks Commodities Corporate Corporate Actions Crypto Cryptocurrency Dividends Earnings Economic Data Forex IPOs Insider Trading Legal M&A Macro Market Update Markets Ratings Regulations Technology
Coverage
Methodology
FAQ

AstraZeneca Bounds Into A Chase Zone As Cancer Drugs Drive Sales Beat

Published 2 days ago • Nov 6, 2025 at 5:12 PM • Positive
AstraZeneca Bounds Into A Chase Zone As Cancer Drugs Drive Sales Beat
Auto
AstraZeneca stock bounded into a buy zone Thursday after sales of its cancer drugs beat Wall Street's expectations by about 5%.

Continue Reading

View Comments

More News

FLR DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Fluor Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – FLR

12 minutes ago Positive

AI Meets Digital Assets: CreditBlockchain Launches Free Cloud Trial for XRP Investors Era

21 minutes ago Positive

Earnings Scorecard: All S&P 500 real estate companies meet earnings estimates

32 minutes ago Positive

Want to retire worry-free? Here are some simple ways to do it.

32 minutes ago Positive

Eli Lilly And These AI Plays Lead 5 Stocks Near Buy Points

42 minutes ago Positive

Trading.HK

Your comprehensive platform for global financial markets data, analytics, and insights.

Markets

  • Asia Pacific
  • Americas
  • Europe
  • Market Status

Asset Classes

  • Equities
  • Cryptocurrency
  • ETFs
  • Forex
  • Commodities

Resources

  • Market News
  • Analytics
  • Stock Screener
  • Compare Stocks
  • Methodology
  • Coverage
  • FAQ

© 2025 Trading.HK. All rights reserved.

Privacy Policy Terms of Service Contact